Category Archives: Recent News

BriaCell Moves Forward to Initiate Phase I/IIa Clinical Study for BriaVax™ in Advanced Breast Cancer
February 6, 2017

Berkeley, CA and Vancouver, BC – February 6, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Included in the List of Key Players in Immuno-Oncology – Genome Web Interviews BriaCell’s Head of R&D –
January 5, 2017

Berkeley, CA and Vancouver, BC – January 5, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell to Present at a Breast Cancer Symposium, and Enters into a Research Agreement with Terasaki Foundation Laboratory
December 5, 2016

Berkeley, CA and Vancouver, BC – December 5, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Files a Patent Application for its Companion Diagnostic Platform to complement BriaVax™
November 29, 2016

Berkeley, CA and Vancouver, BC – November 29, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Provides Clinical Development Update on BriaVax™
November 10, 2016

Berkeley, CA and Vancouver, BC – November 10, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces the Appointment of Biotechnology Veteran William Williams as New CEO and Director
October 26, 2016

Berkeley, CA and Vancouver, BC – October 26, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BioNap Consulting’s Jason Napodano Issues an Update on BriaCell Therapeutics Corp.
September 27, 2016

Berkeley, CA and Vancouver, BC–(Marketwired – September 27, 2016) – BioNap Consulting, Inc.’s Senior Equity ...

BriaCell Appoints New York-Based RK Equity Advisors and TrueNorth LifeScience a Corporate Advisor
September 15, 2016

Berkeley, CA and Vancouver, BC – September 15, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Closes Oversubscribed Non-Brokered Private Placement
August 19, 2016

BERKELEY, CALIFORNIA and VANCOUVER, BRITISH COLUMBIA–(Marketwired – Aug. 19, 2016) – BriaCell Therapeutics Corp. (“BriaCell” ...

BriaCell Appoints the Lead Principal Investigator and First Clinical Site for its Upcoming Phase I/IIa Clinical Trial in Advanced Breast Cancer
August 17, 2016

– Dr. Jarrod P. Holmes, a prominent breast cancer vaccine expert to lead the study ...

Skip to content